SCHEMBL9533625

SCHEMBL9533625

CCn1c(CF)c(CCC(C)C)n(Cc2ccc(-c3ccccc3C(=O)O)cc2)c1=O

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 3/20 0.48
AGTR2 P50052 3/20 0.48
PPARG P37231 2/20 0.47
BRS3 P32247 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9734181 0.95 PPARG (0.46) AGTR1AGTR2PPARGBRS3
SCHEMBL9534250 0.95 BRS3 (0.49) AGTR1AGTR2PPARGBRS3
SCHEMBL9533923 0.93 AGTR1 (0.52) AGTR1AGTR2PPARG
SCHEMBL9536641 0.92 BRS3 (0.47) AGTR1AGTR2PPARGBRS3
SCHEMBL9531420 0.92 AGTR1 (0.48) AGTR1AGTR2PPARGBRS3
SCHEMBL9036788 0.91 AGTR1 (0.57) AGTR1AGTR2
SCHEMBL9532530 0.91 BRS3 (0.48) AGTR1AGTR2PPARGBRS3
SCHEMBL9554709 0.90 PPARG (0.55) AGTR1AGTR2PPARG
SCHEMBL9540097 0.90 AGTR1 (0.54) AGTR1AGTR2PPARG
SCHEMBL9536241 0.89 AGTR1 (0.49) AGTR1AGTR2PPARGBRS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed